The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...

The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...

Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...

The burden of presbyopia and reading glasses drives patients to look for solutions.“There is a clear and growing patient demand for noninvasive, reversible options to manage presbyopia,” Behnaz ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...

When presbyopia eye drops first came out, there was a real fear among surgeons about whether drops would replace surgery. Are ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

Tenpoint Therapeutics announced FDA’s approval of Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% ...

The likelihood of needing reading glasses grows as you get older. Learn the key signs of presbyopia, or age-related ...

Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, ...

If you’re over age 40 and you notice that words are starting to seem blurrier when you read, you’re not going crazy. There’s a good chance you’re experiencing presbyopia. Presbyopia is an age-related, ...